0001213900-23-004230.txt : 20230120
0001213900-23-004230.hdr.sgml : 20230120
20230120201140
ACCESSION NUMBER: 0001213900-23-004230
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230105
FILED AS OF DATE: 20230120
DATE AS OF CHANGE: 20230120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mikhak Zamaneh
CENTRAL INDEX KEY: 0001962453
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39102
FILM NUMBER: 23542310
MAIL ADDRESS:
STREET 1: 1751 RIVER RUN, SUITE 400
STREET 2: C/O TFF PHARMACEUTICALS, INC.
CITY: FORT WORTH
STATE: TX
ZIP: 76107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TFF Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001733413
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 824344737
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2600 VIA FORTUNA, SUITE 360
CITY: AUSTIN
STATE: TX
ZIP: 78746
BUSINESS PHONE: 737-802-1973
MAIL ADDRESS:
STREET 1: 2600 VIA FORTUNA, SUITE 360
CITY: AUSTIN
STATE: TX
ZIP: 78746
3
1
ownership.xml
X0206
3
2023-01-05
0
0001733413
TFF Pharmaceuticals, Inc.
TFFP
0001962453
Mikhak Zamaneh
1751 RIVER RUN, SUITE 400
FORT WORTH
TX
76107
0
1
0
0
Chief Medical Officer
Stock Option (Right to Buy)
0.97
2032-12-21
Common Stock
430000
D
The Options shall vest and first become exercisable as follows: one quarter of the Options shall vest and first become exercisable on December 21, 2023, and the remainder of the Options shall vest and first become exercisable in 12 equal quarterly installments commencing on March 31, 2024.
/s/ Zamaneh Mikhak
2023-01-20